Lv1
6 积分 2024-08-12 加入
Divalent cannabinoid-1 receptor ligands: A linker attachment point survey of SR141716A for development of high-affinity CB1R molecular probes
10天前
已完结
Discovery of selective irreversible inhibitors of B-Lymphoid tyrosine kinase (BLK)
10天前
已完结
Discovery of Novel 4,5,6,7-Tetrahydro-7H-pyrazolo[3,4-c]pyridin-7-one Derivatives as Orally Efficacious ATX Allosteric Inhibitors for the Treatment of Pulmonary Fibrosis
10天前
已完结
Discovery and Proof of Concept of Potent Dual Polθ/PARP Inhibitors for Efficient Treatment of Homologous Recombination-Deficient Tumors
11天前
已完结
Rational Design of PARP1/c-Met Dual Inhibitors for Overcoming PARP1 Inhibitor Resistance Induced by c-Met Overexpression
11天前
已完结
Design, Synthesis, and Evaluation in Vitro of Quinoline-8-carboxamides, a New Class of Poly(adenosine-diphosphate-ribose)polymerase-1 (PARP-1) Inhibitor
14天前
已完结
Discovery of dual PARP and CDK6 inhibitors for triple-negative breast cancer with wild-type BRCA
16天前
已完结
Self-amplifying nanomedicine reprograms redox metabolism to trigger immunogenic ferroptosis in colon cancer: multiomics identifies AMPD3 as a novel regulator
17天前
已完结
Development and evaluation of a 99mTc-labeled olaparib analog for PARP imaging
22天前
已完结
Recent advances of quinoline‐based small molecules as kinase inhibitors (2020‐2024)
25天前
已完结
皖公网安备34019202002308
